E. Cohen-Jonathan

发表

Preferential cytoplasmic localization of p34cdc2 in recurrent human squamous cell carcinoma after radiotherapy.

E. Cohen-Jonathan, C. Toulas, P. Rochaix, 1997, Radiation research.

Inhibiting Signal Transduction as an Approach to Radiosensitizing Tumor Cells

R. Muschel, S. Hahn, E. Bernhard, 2003 .

The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit

E. Cohen-Jonathan, C. Toulas, G. Favre, 2002, Oncogene.

Prenyltransferase Inhibitors as Radiosensitizers

R. Muschel, S. Sebti, E. Bernhard, 2001 .

Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells.

H. Prats, E. Cohen-Jonathan, C. Toulas, 1997, Cancer research.

The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.

R. Muschel, E. Bernhard, C. Koch, 2001, Cancer research.

Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.

M. Barberi-Heyob, J. Merlin, E. Cohen-Jonathan, 2004, International journal of radiation oncology, biology, physics.

The Farnesyltransferase Inhibitor L 744 , 832 Reduces Hypoxia in Tumors Expressing

R. Muschel, E. Bernhard, C. Koch, 2001 .

Farnesyltransferase inhibitor effects on prostate tumor micro‐environment and radiation survival

J. Rhim, E. Bernhard, E. Cohen-Jonathan, 2005, The Prostate.

The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS.

S. Sebti, E. Cohen-Jonathan, C. Toulas, 1999, Radiation research.

The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.

E. Cohen-Jonathan, C. Toulas, P. Rochaix, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial.

E. Cohen-Jonathan, J. Bachaud, N. Daly-Schveitzer, 1996, International journal of radiation oncology, biology, physics.

Farnesyltransferase Inhibitors Potentiate the Antitumor Effect of Radiation on a Human Tumor Xenograft Expressing Activated HRAS1

R. Muschel, D. Kusewitt, S. Sebti, 2000, Radiation research.

Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation

E. Cohen-Jonathan, C. Toulas, G. Favre, 2002, International journal of cancer.

Increased expression of a COOH‐truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells

Florence Dalenc, Gilles Favre, E. Cohen-Jonathan, 2002, International journal of cancer.

Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplication

E. Cohen-Jonathan, C. Toulas, G. Favre, 2005, Cell Death and Differentiation.

RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death

E. Cohen-Jonathan, C. Toulas, G. Favre, 2002, Oncogene.